Ssibon Pharmaceutical Private Limited
About Ssibon Pharmaceutical Private Limited
Data last updated:
Ssibon Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2019PTC343679. Its GSTIN is 07ABBCS3513P1Z4 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tuleshwar Singh and Neeta Singh Rajpoot.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.71 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹13,530 (net margin 0.4%) and EBITDA of ₹13,530 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 33% over five years.
Company details
Contact details
Ssibon Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Ssibon Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ssibon Pharmaceutical is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Ssibon Pharmaceutical Private Limited, buy the company report.
Financials of Ssibon Pharmaceutical Private Limited
FY 2025 filings availableSsibon Pharmaceutical Private Limited reported revenue of ₹30.71 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 33% over five years, including 19% growth in the latest year. EBITDA rose 120% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13,530 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,530 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ssibon Pharmaceutical Private Limited, buy the company report.
Board of directors of Ssibon Pharmaceutical Private Limited
Ssibon Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tuleshwar Singh | Director | 01 Jan 2019 | 7 Years 9 Months | Current |
| Neeta Singh Rajpoot | Director | 01 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Ssibon Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Festive Realcon Private Limited | ₹30.72 Lakh (FY 2024) | 740.0% | Kolkata, West Bengal, India | |||
| House of Aynaa Private Limited | ₹30.72 Lakh (FY 2025) | -40.0% | Indore, Madhya Pradesh, India | |||
| Evershine Fabrics Private Limited | ₹30.72 Lakh (FY 2019) | -65.0% | Kothapet X Road, Telangana, India | |||
| Crop Matrix Private Limited | ₹30.72 Lakh (FY 2024) | 420746.0% | Lucknow, Uttar Pradesh, India | |||
| Precision Ceramics Pvt Ltd | ₹30.72 Lakh (FY 2024) | -12.0% | Kolkata, West Bengal, India | |||
| Ssibon Pharmaceutical Private Limitedthis company | ₹30.71 Lakh (FY 2025) | ₹13,530 | 0.4% | 19.0% | New Delhi, Delhi, India | |
| Murli Foods (India) Pvt Ltd. | ₹30.71 Lakh (FY 2025) | -33.0% | Kolkata, West Bengal, India | |||
| Shiv-Shambho Consultants Private Limited | ₹30.7 Lakh (FY 2024) | New Delhi, Delhi, India | ||||
| Margaux Style and Accessories Private Limited | ₹30.7 Lakh (FY 2025) | 139.0% | Delhi, India | |||
| Shree Khyatija Tradelink Private Limited | ₹30.69 Lakh (FY 2023) | 28.0% | Pune, Maharashtra, India | |||
| Pioneer Lifesciences Enterprises Private Limited | ₹30.69 Lakh (FY 2025) | -89.0% | New Delhi, Delhi, India |
To see the full peer comparison of Ssibon Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ssibon Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ssibon Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ssibon Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABBCS3513P1Z4 | Delhi | Active | 11 Jan 2019 |
To see the full GST registrations and return filing status of Ssibon Pharmaceutical Private Limited, buy the company report.
Recent activity
Ssibon Pharmaceutical Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Neeta Singh Rajpoot was appointed as Director on 01 Jan 2019.
Frequently asked questions
Ssibon Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 January 2019 (7+ years old) and is registered under CIN U51909DL2019PTC343679.
Ssibon Pharmaceutical has 2 current directors:
- Tuleshwar Singh - Director
- Neeta Singh Rajpoot - Director
The latest financial statements of Ssibon Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Ssibon Pharmaceutical is 07ABBCS3513P1Z4, registered in Delhi.
The CIN (Corporate Identification Number) of Ssibon Pharmaceutical is U51909DL2019PTC343679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ssibon Pharmaceutical was incorporated on 01 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ssibon Pharmaceutical by revenue are Festive Realcon Private Limited, House of Aynaa Private Limited, Evershine Fabrics Private Limited, Crop Matrix Private Limited, Precision Ceramics Pvt Ltd and 5 more, all in the same principal business activity (retail trading).
Neeta Singh Rajpoot was appointed as Director on 01 Jan 2019. Tuleshwar Singh was appointed as Director on 01 Jan 2019.
The registered office of Ssibon Pharmaceutical is at 269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.
Ssibon Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Ssibon Pharmaceutical can be reached at its registered office: 269 A First Floor Front Side Flat No. 9 Asola Fatehpur Beri, New Delhi, Delhi, India – 110074.